Fingerprint
Dive into the research topics of 'Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically